Find a Clinical Trial
Filter
PATH-2: PLS240
Hemodialysis access, Thyroid diseases
All genders
18-80
Recruiting now
Division of Nephrology
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Relapsed or refractory myeloma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
MLS-101-206
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
M23-362
Diffuse large B-cell lymphoma, Follicular lymphoma, Lymphomas (adult)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HGB-210
Sickle cell anemia
All genders
2-50
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
R3R
Chronic kidney disease
All genders
12+
Recruiting now
Department of Medicine, Division of Nephrology
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Diffuse large B-cell lymphoma
All genders
75+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Assist
Chronic kidney disease
All genders
18+
Recruiting now
Department of Medicine, Division of Nephrology
VX19-NEN-801
Chronic kidney disease, Glomerular disease, Kidney diseases, Proteinuria
All genders
12-65
Recruiting now
Department of Medicine, Division of Nephrology